miR-125a-5p impairs the metastatic potential in breast cancer via IP6K1 targeting.
Minini M, Senni A, He X, Proietti S, Liguoro D, Catizone A, Giuliani A, Mancini R, Fuso A, Cucina A, Cao Y, Bizzarri M.
Minini M, et al.
Cancer Lett. 2021 Nov 1;520:48-56. doi: 10.1016/j.canlet.2021.07.001. Epub 2021 Jul 3.
Cancer Lett. 2021.
PMID: 34229060